Research maps testing models for head and neck cancer drug development

A new review examines preclinical laboratory and animal models used to evaluate experimental treatments for head and neck squamous cell carcinoma, a cancer affecting thousands annually. Understanding which models best predict real-world drug performance could accelerate development timelines and reduce costly late-stage clinical trial failures.

Originaltitel: Preclinical models in head and neck squamous cell carcinoma